← BPC-157 overview

BPC-157 Dosage & Reconstitution Guide

Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.

Typical dose
200-500 mcg
Route
Subcutaneous injection
Frequency
once or twice daily
After mixing
5 mg/mL (5000 mcg/mL)

Reconstitution

BPC-157 ships as a freeze-dried (lyophilized) powder that has to be mixed with bacteriostatic water before use. Draw 2 mL of bacteriostatic water into a syringe and add it to a 10 mg vial, letting the stream run down the inside wall of the glass rather than blasting the powder directly. Swirl gently — never shake — until the solution is clear, then keep it refrigerated.

Worked example. 2 mL into a 10 mg vial gives a concentration of 5 mg/mL (5000 mcg/mL). A 500 mcg dose then works out to 0.1 mL = 10 units on a U-100 insulin syringe. Scale the water volume up or down to make your target dose land on an easy-to-read mark (1 unit = 0.01 mL).

  1. Wipe both vial stoppers (peptide and bacteriostatic water) with an alcohol swab and let them dry.
  2. Draw 2 mL of bacteriostatic water into a syringe.
  3. Inject it slowly against the inside wall of the peptide vial.
  4. Swirl gently until fully dissolved; do not shake.
  5. Label the vial with the contents, concentration, and date, and store it in the refrigerator.

Dosing schedule

Phase Dose Volume Insulin units (U-100) Notes
Week 1 250 mcg 0.05 mL 5 units once daily
Weeks 2–4 250 mcg 0.05 mL 5 units twice daily (500 mcg/day)
Alternative 500 mcg 0.1 mL 10 units single daily dose

Timing & cycling

Timing is flexible. Many split the day's total into a morning and an evening shot; injecting near (not into) an injured area is common practice, though systemic effect appears similar either way.

Cycle length. 4–8 weeks per course, followed by at least 2 weeks off.

Storage & handling

Keep the lyophilized (unmixed) vial refrigerated at 2–8 °C (36–46 °F) in a dry, dark place — it tolerates short periods at room temperature during shipping. Once reconstituted, store it at 2–8 °C, never frozen, and use it within about 2–4 weeks (sooner if the solution turns cloudy or discolored). Swab the stopper before every draw and use a fresh needle each time.

Supplies you'll need

  • BPC-157 vials — about 6 for an 8-week run at the upper dose
  • Bacteriostatic water — 2 mL per vial (a 10–30 mL multi-dose bottle covers several vials)
  • U-100 insulin syringes (0.3–0.5 mL / 30–50 unit barrels are easiest to read) — roughly 112 for 8 weeks, plus spares
  • Alcohol swabs — one per injection and one per vial draw
  • Sharps container for safe needle disposal

Key points

  • For gut-focused runs, oral/intragastric dosing at the same daily totals is widely reported.
  • One 5 mg vial covers roughly 10–20 days at 250–500 mcg per day.
  • Very well tolerated in reports; most complaints are local injection-site irritation.

What to monitor

No standard labs; track the injury or symptom you are running it for.

Legal & prescription status

No legal prescription exists. It is an unapproved research chemical, sold only for laboratory research and labelled 'not for human consumption.' It is not FDA-approved for any human use.

References

  1. pubmed.ncbi.nlm.nih.gov
  2. pubmed.ncbi.nlm.nih.gov
  3. pubmed.ncbi.nlm.nih.gov
  4. pubmed.ncbi.nlm.nih.gov
  5. pubmed.ncbi.nlm.nih.gov
  6. ncbi.nlm.nih.gov
  7. journals.physiology.org
  8. mdpi.com
  9. josr-online.biomedcentral.com
  10. pubmed.ncbi.nlm.nih.gov

This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.